Fish oil–derived n–3 PUFA therapy increases muscle mass and function in healthy older adults
Background: Age-associated declines in muscle mass and function are major risk factors for an impaired ability to carry out activities of daily living, falls, prolonged recovery time after hospitalization, and mortality in older adults. New strategies that can slow the age-related loss of muscle mas...
Saved in:
| Published in | The American journal of clinical nutrition Vol. 102; no. 1; pp. 115 - 122 |
|---|---|
| Main Authors | , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
United States
American Society for Clinical Nutrition
01.07.2015
American Society for Clinical Nutrition, Inc American Society for Nutrition |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Background: Age-associated declines in muscle mass and function are major risk factors for an impaired ability to carry out activities of daily living, falls, prolonged recovery time after hospitalization, and mortality in older adults. New strategies that can slow the age-related loss of muscle mass and function are needed to help older adults maintain adequate performance status to reduce these risks and maintain independence. Objective: We evaluated the efficacy of fish oil–derived n–3 (ω -3) PUFA therapy to slow the age-associated loss of muscle mass and function. Design: Sixty healthy 60–85-y-old men and women were randomly assigned to receive n–3 PUFA (n = 40) or corn oil (n = 20) therapy for 6 mo. Thigh muscle volume, handgrip strength, one-repetition maximum (1-RM) lower- and upper-body strength, and average power during isokinetic leg exercises were evaluated before and after treatment. Results: Forty-four subjects completed the study [29 subjects (73%) in the n–3 PUFA group; 15 subjects (75%) in the control group]. Compared with the control group, 6 mo of n–3 PUFA therapy increased thigh muscle volume (3.6%; 95% CI: 0.2%, 7.0%), handgrip strength (2.3 kg; 95% CI: 0.8, 3.7 kg), and 1-RM muscle strength (4.0%; 95% CI: 0.8%, 7.3%) (all P < 0.05) and tended to increase average isokinetic power (5.6%; 95% CI: −0.6%, 11.7%; P = 0.075). Conclusion: Fish oil–derived n–3 PUFA therapy slows the normal decline in muscle mass and function in older adults and should be considered a therapeutic approach for preventing sarcopenia and maintaining physical independence in older adults. This study was registered at clinicaltrials.gov as NCT01308957. |
|---|---|
| AbstractList | Background: Age-associated declines in muscle mass and function are major risk factors for an impaired ability to carry out activities of daily living, falls, prolonged recovery time after hospitalization, and mortality in older adults. New strategies that can slow the age-related loss of muscle mass and function are needed to help older adults maintain adequate performance status to reduce these risks and maintain independence. Objective: We evaluated the efficacy of fish oil–derived n–3 (ω -3) PUFA therapy to slow the age-associated loss of muscle mass and function. Design: Sixty healthy 60–85-y-old men and women were randomly assigned to receive n–3 PUFA (n = 40) or corn oil (n = 20) therapy for 6 mo. Thigh muscle volume, handgrip strength, one-repetition maximum (1-RM) lower- and upper-body strength, and average power during isokinetic leg exercises were evaluated before and after treatment. Results: Forty-four subjects completed the study [29 subjects (73%) in the n–3 PUFA group; 15 subjects (75%) in the control group]. Compared with the control group, 6 mo of n–3 PUFA therapy increased thigh muscle volume (3.6%; 95% CI: 0.2%, 7.0%), handgrip strength (2.3 kg; 95% CI: 0.8, 3.7 kg), and 1-RM muscle strength (4.0%; 95% CI: 0.8%, 7.3%) (all P < 0.05) and tended to increase average isokinetic power (5.6%; 95% CI: −0.6%, 11.7%; P = 0.075). Conclusion: Fish oil–derived n–3 PUFA therapy slows the normal decline in muscle mass and function in older adults and should be considered a therapeutic approach for preventing sarcopenia and maintaining physical independence in older adults. This study was registered at clinicaltrials.gov as NCT01308957. Background: Age-associated declines in muscle mass and function are major risk factors for an impaired ability to carry out activities of daily living, falls, prolonged recovery time after hospitalization, and mortality in older adults. New strategies that can slow the age-related loss of muscle mass and function are needed to help older adults maintain adequate performance status to reduce these risks and maintain independence. Objective: We evaluated the efficacy of fish oil–derived n–3 ( ω -3) PUFA therapy to slow the age-associated loss of muscle mass and function. Design: Sixty healthy 60–85-y-old men and women were randomly assigned to receive n–3 PUFA ( n = 40) or corn oil ( n = 20) therapy for 6 mo. Thigh muscle volume, handgrip strength, one-repetition maximum (1-RM) lower- and upper-body strength, and average power during isokinetic leg exercises were evaluated before and after treatment. Results: Forty-four subjects completed the study [29 subjects (73%) in the n–3 PUFA group; 15 subjects (75%) in the control group]. Compared with the control group, 6 mo of n–3 PUFA therapy increased thigh muscle volume (3.6%; 95% CI: 0.2%, 7.0%), handgrip strength (2.3 kg; 95% CI: 0.8, 3.7 kg), and 1-RM muscle strength (4.0%; 95% CI: 0.8%, 7.3%) (all P < 0.05) and tended to increase average isokinetic power (5.6%; 95% CI: −0.6%, 11.7%; P = 0.075). Conclusion: Fish oil–derived n–3 PUFA therapy slows the normal decline in muscle mass and function in older adults and should be considered a therapeutic approach for preventing sarcopenia and maintaining physical independence in older adults. This study was registered at clinicaltrials.gov as NCT01308957. Age-associated declines in muscle mass and function are major risk factors for an impaired ability to carry out activities of daily living, falls, prolonged recovery time after hospitalization, and mortality in older adults. New strategies that can slow the age-related loss of muscle mass and function are needed to help older adults maintain adequate performance status to reduce these risks and maintain independence. We evaluated the efficacy of fish oil-derived n-3 (...-3) PUFA therapy to slow the age-associated loss of muscle mass and function. Sixty healthy 60-85-y-old men and women were randomly assigned to receive n-3 PUFA (n = 40) or corn oil (n = 20) therapy for 6 mo. Thigh muscle volume, handgrip strength, one-repetition maximum (1-RM) lower- and upper-body strength, and average power during isokinetic leg exercises were evaluated before and after treatment. Forty-four subjects completed the study [29 subjects (73%) in the n-3 PUFA group; 15 subjects (75%) in the control group]. Compared with the control group, 6 mo of n-3 PUFA therapy increased thigh muscle volume (3.6%; 95% CI: 0.2%, 7.0%), handgrip strength (2.3 kg; 95% CI: 0.8, 3.7 kg), and 1-RM muscle strength (4.0%; 95% CI: 0.8%, 7.3%) (all P < 0.05) and tended to increase average isokinetic power (5.6%; 95% CI: -0.6%, 11.7%; P = 0.075). Fish oil-derived n-3 PUFA therapy slows the normal decline in muscle mass and function in older adults and should be considered a therapeutic approach for preventing sarcopenia and maintaining physical independence in older adults. (ProQuest: ... denotes formulae/symbols omitted.) Background: Age-associated declines in muscle mass and function are major risk factors for an impaired ability to carry out activities of daily living, falls, prolonged recovery time after hospitalization, and mortality in older adults. New strategies that can slow the age-related loss of muscle mass and function are needed to help older adults maintain adequate performance status to reduce these risks and maintain independence. Objective: We evaluated the efficacy of fish oil-derived n-3 (omega-3) PUFA therapy to slow the age-associated loss of muscle mass and function. Design: Sixty healthy 60-85-y-old men and women were randomly assigned to receive n-3 PUFA (n = 40) or corn oil (n = 20) therapy for 6 mo. Thigh muscle volume, handgrip strength, one-repetition maximum (1-RM) lower- and upper-body strength, and average power during isokinetic leg exercises were evaluated before and after treatment. Results: Forty-four subjects completed the study [29 subjects (73%) in the n-3 PUFA group; 15 subjects (75%) in the control group]. Compared with the control group, 6 mo of n-3 PUFA therapy increased thigh muscle volume (3.6%; 95% CI: 0.2%, 7.0%), handgrip strength (2.3 kg; 95% CI: 0.8, 3.7 kg), and 1-RM muscle strength (4.0%; 95% CI: 0.8%, 7.3%) (all P < 0.05) and tended to increase average isokinetic power (5.6%; 95% CI: -0.6%, 11.7%; P = 0.075). Conclusion: Fish oil-derived n-3 PUFA therapy slows the normal decline in muscle mass and function in older adults and should be considered a therapeutic approach for preventing sarcopenia and maintaining physical independence in older adults. BACKGROUNDAge-associated declines in muscle mass and function are major risk factors for an impaired ability to carry out activities of daily living, falls, prolonged recovery time after hospitalization, and mortality in older adults. New strategies that can slow the age-related loss of muscle mass and function are needed to help older adults maintain adequate performance status to reduce these risks and maintain independence.OBJECTIVEWe evaluated the efficacy of fish oil-derived n-3 (ω-3) PUFA therapy to slow the age-associated loss of muscle mass and function.DESIGNSixty healthy 60-85-y-old men and women were randomly assigned to receive n-3 PUFA (n = 40) or corn oil (n = 20) therapy for 6 mo. Thigh muscle volume, handgrip strength, one-repetition maximum (1-RM) lower- and upper-body strength, and average power during isokinetic leg exercises were evaluated before and after treatment.RESULTSForty-four subjects completed the study [29 subjects (73%) in the n-3 PUFA group; 15 subjects (75%) in the control group]. Compared with the control group, 6 mo of n-3 PUFA therapy increased thigh muscle volume (3.6%; 95% CI: 0.2%, 7.0%), handgrip strength (2.3 kg; 95% CI: 0.8, 3.7 kg), and 1-RM muscle strength (4.0%; 95% CI: 0.8%, 7.3%) (all P < 0.05) and tended to increase average isokinetic power (5.6%; 95% CI: -0.6%, 11.7%; P = 0.075).CONCLUSIONFish oil-derived n-3 PUFA therapy slows the normal decline in muscle mass and function in older adults and should be considered a therapeutic approach for preventing sarcopenia and maintaining physical independence in older adults. This study was registered at clinicaltrials.gov as NCT01308957. Age-associated declines in muscle mass and function are major risk factors for an impaired ability to carry out activities of daily living, falls, prolonged recovery time after hospitalization, and mortality in older adults. New strategies that can slow the age-related loss of muscle mass and function are needed to help older adults maintain adequate performance status to reduce these risks and maintain independence. We evaluated the efficacy of fish oil-derived n-3 (ω-3) PUFA therapy to slow the age-associated loss of muscle mass and function. Sixty healthy 60-85-y-old men and women were randomly assigned to receive n-3 PUFA (n = 40) or corn oil (n = 20) therapy for 6 mo. Thigh muscle volume, handgrip strength, one-repetition maximum (1-RM) lower- and upper-body strength, and average power during isokinetic leg exercises were evaluated before and after treatment. Forty-four subjects completed the study [29 subjects (73%) in the n-3 PUFA group; 15 subjects (75%) in the control group]. Compared with the control group, 6 mo of n-3 PUFA therapy increased thigh muscle volume (3.6%; 95% CI: 0.2%, 7.0%), handgrip strength (2.3 kg; 95% CI: 0.8, 3.7 kg), and 1-RM muscle strength (4.0%; 95% CI: 0.8%, 7.3%) (all P < 0.05) and tended to increase average isokinetic power (5.6%; 95% CI: -0.6%, 11.7%; P = 0.075). Fish oil-derived n-3 PUFA therapy slows the normal decline in muscle mass and function in older adults and should be considered a therapeutic approach for preventing sarcopenia and maintaining physical independence in older adults. This study was registered at clinicaltrials.gov as NCT01308957. |
| Author | Smith, Gordon I Sinacore, David R Julliand, Sophie Reeds, Dominic N Mittendorfer, Bettina Klein, Samuel |
| Author_xml | – sequence: 1 fullname: Smith, Gordon I – sequence: 2 fullname: Julliand, Sophie – sequence: 3 fullname: Reeds, Dominic N – sequence: 4 fullname: Sinacore, David R – sequence: 5 fullname: Klein, Samuel – sequence: 6 fullname: Mittendorfer, Bettina |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/25994567$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFkk9rFDEYxoNU7LZ69qYBL15mm_9_LkIpbhUKCrbnmM4knSwzyZrMFPbmd_Ab-kmaZVvRgvSUF_J7Hnje9zkCBzFFB8BrjJZUM35i121cYsyWGHFF6TOwwJqqhhIkD8ACIUQajQU_BEelrBHChCnxAhwSrqtayAX4vgqlhykMv3_-6lwOt66Dsc4Ufr1ancKpd9lutjDENjtbXIHjXNrBwdGWAm3soJ9jO4UUKwJ7Z4ep38I0VCtou3mYykvw3NuhuFf37zG4XH28PPvUXHw5_3x2etG0XMqp0doi5i3RlDDhkXKeWOadEtwqJhXrSMe8by0j3GumhULEd9JJJK8plZwegw972818PbqudXHKdjCbHEabtybZYP79iaE3N-nWMKaQELIavL83yOnH7MpkxlBaNww2ujQXgxXhClNZ9_s0iijGmjP1NCo0lUhohir67hG6TnOOdWc7iiNKEWOVevN3zj8BHy5aAb4H2pxKyc6bNkx2d6EaOwwGI7Nrjtk1x9TmmH1zqu7kke7B-v-Kt3uFt8nYmxyKufpGEBa1dkqIitwBLKrQAA |
| CitedBy_id | crossref_primary_10_3390_nu15020321 crossref_primary_10_3390_nu15132956 crossref_primary_10_3945_an_116_014506 crossref_primary_10_4158_EP_2019_0144 crossref_primary_10_1139_apnm_2015_0350 crossref_primary_10_1111_bph_15671 crossref_primary_10_3389_fnut_2019_00131 crossref_primary_10_3390_nu12113367 crossref_primary_10_1093_ajcn_nqaa150 crossref_primary_10_1096_fj_201801857RRR crossref_primary_10_1093_bbb_zbae035 crossref_primary_10_1007_s00223_019_00584_3 crossref_primary_10_1007_s11695_019_03814_7 crossref_primary_10_1371_journal_pone_0212449 crossref_primary_10_1016_j_exger_2024_112612 crossref_primary_10_3390_nu15163579 crossref_primary_10_1111_obr_12776 crossref_primary_10_1007_s12649_023_02072_0 crossref_primary_10_1038_s41598_022_23545_7 crossref_primary_10_3389_fphys_2021_634953 crossref_primary_10_3390_nu14112221 crossref_primary_10_1097_MCO_0000000000000827 crossref_primary_10_3389_fphys_2019_01129 crossref_primary_10_37586_2686_8636_1_2023_29_38 crossref_primary_10_4163_jnh_2023_56_2_155 crossref_primary_10_1007_s40279_024_02072_7 crossref_primary_10_1016_j_dsx_2023_102835 crossref_primary_10_1017_S0007114517001118 crossref_primary_10_3390_nu14122374 crossref_primary_10_3389_fnut_2024_1379814 crossref_primary_10_14336_AD_2021_0818 crossref_primary_10_1093_nutrit_nuaa034 crossref_primary_10_1136_bmjopen_2018_022877 crossref_primary_10_3390_metabo11080517 crossref_primary_10_3390_nu13010114 crossref_primary_10_1519_JSC_0000000000002758 crossref_primary_10_1016_j_clnesp_2025_03_012 crossref_primary_10_1111_obr_13197 crossref_primary_10_1186_s12970_020_00379_0 crossref_primary_10_1089_ict_2023_29110_klu crossref_primary_10_3390_md20110716 crossref_primary_10_1152_ajpendo_00438_2015 crossref_primary_10_1139_apnm_2024_0256 crossref_primary_10_3390_nu15183964 crossref_primary_10_1016_j_clnesp_2021_06_015 crossref_primary_10_3390_nu12092597 crossref_primary_10_3390_nu16111650 crossref_primary_10_15857_ksep_2019_28_4_317 crossref_primary_10_3390_nu16203428 crossref_primary_10_1017_S0029665123004834 crossref_primary_10_1515_revneuro_2021_0013 crossref_primary_10_1093_nutrit_nuy062 crossref_primary_10_1097_MCO_0000000000000723 crossref_primary_10_3389_fnut_2021_746880 crossref_primary_10_1007_s11154_025_09947_8 crossref_primary_10_1371_journal_pone_0312523 crossref_primary_10_18632_aging_202655 crossref_primary_10_3390_nu12123712 crossref_primary_10_1007_s40520_019_01146_1 crossref_primary_10_1093_ije_dyz196 crossref_primary_10_2174_1874467216666230308142137 crossref_primary_10_1113_JP276504 crossref_primary_10_1002_j_2617_1619_2018_tb00006_x crossref_primary_10_1051_ocl_2019032 crossref_primary_10_3390_nu11010046 crossref_primary_10_1039_D2FO03338K crossref_primary_10_1017_S0029665120007119 crossref_primary_10_3389_fnut_2019_00144 crossref_primary_10_3389_fphys_2017_01045 crossref_primary_10_1093_ageing_afx164 crossref_primary_10_1177_11786388211022378 crossref_primary_10_1016_j_jot_2020_04_002 crossref_primary_10_3390_nu13061914 crossref_primary_10_3390_nu9101100 crossref_primary_10_1002_cam4_3428 crossref_primary_10_1152_japplphysiol_00924_2016 crossref_primary_10_5468_ogs_2020_63_3_305 crossref_primary_10_1016_j_advnut_2022_11_005 crossref_primary_10_3390_ijms25168793 crossref_primary_10_1139_apnm_2019_0721 crossref_primary_10_3390_md21070399 crossref_primary_10_3390_nu13020293 crossref_primary_10_17987_jcsm_cr_v2i2_45 crossref_primary_10_1016_j_bbrep_2019_100622 crossref_primary_10_1017_S0007114523002386 crossref_primary_10_3390_nu10050552 crossref_primary_10_3390_nu12072139 crossref_primary_10_1016_j_mad_2020_111269 crossref_primary_10_1186_s13075_018_1579_y crossref_primary_10_1016_j_arr_2024_102267 crossref_primary_10_1016_j_mad_2021_111441 crossref_primary_10_3390_nu16132044 crossref_primary_10_1016_j_clnu_2024_08_004 crossref_primary_10_1016_j_jnutbio_2018_02_012 crossref_primary_10_3390_nu11081931 crossref_primary_10_1017_S1368980021002184 crossref_primary_10_3390_nu10091180 crossref_primary_10_1016_j_clnesp_2019_05_009 crossref_primary_10_1016_j_maturitas_2019_11_007 crossref_primary_10_3390_ijms19010218 crossref_primary_10_3390_nu8090543 crossref_primary_10_1093_ajcn_nqac138 crossref_primary_10_1016_j_psj_2020_05_005 crossref_primary_10_3390_nu12061755 crossref_primary_10_1016_j_clnesp_2021_10_011 crossref_primary_10_1007_s13668_016_0161_y crossref_primary_10_1017_S0007114522001805 crossref_primary_10_1007_s40520_022_02250_5 crossref_primary_10_1097_MCO_0000000000000986 crossref_primary_10_1007_s12603_017_0896_1 crossref_primary_10_1123_ijsnem_2021_0086 crossref_primary_10_1002_jmri_25920 crossref_primary_10_1007_s00394_018_1882_z crossref_primary_10_1155_2020_3576974 crossref_primary_10_3390_nu11122974 crossref_primary_10_1186_s40104_018_0297_2 crossref_primary_10_3390_nu13113884 crossref_primary_10_33549_physiolres_934534 crossref_primary_10_1044_2021_JSLHR_21_00295 crossref_primary_10_1186_s12877_024_05218_4 crossref_primary_10_1096_fj_202400619R crossref_primary_10_1016_j_arr_2023_102106 crossref_primary_10_14814_phy2_12785 crossref_primary_10_17816_clinutr108594 crossref_primary_10_1016_j_clnu_2022_04_007 crossref_primary_10_1097_MCO_0000000000001023 crossref_primary_10_1186_s12877_020_01900_5 crossref_primary_10_1177_17455057241305075 crossref_primary_10_3892_ijfn_2025_45 crossref_primary_10_1123_japa_2018_0351 crossref_primary_10_1007_s00394_021_02773_z crossref_primary_10_1021_acsomega_4c07560 crossref_primary_10_1016_j_jacl_2018_03_080 crossref_primary_10_1039_D2FO02974J crossref_primary_10_1093_nutrit_nuad061 crossref_primary_10_3389_fnut_2023_1325821 crossref_primary_10_1016_j_clnesp_2021_05_002 crossref_primary_10_3390_nu8040181 crossref_primary_10_3390_nu10020224 crossref_primary_10_3389_fphys_2018_01883 crossref_primary_10_1016_j_ajcnut_2024_04_010 crossref_primary_10_1111_nbu_12497 crossref_primary_10_31829_2637_367X_rrm2018_1_1__105 crossref_primary_10_3390_ijerph19148677 crossref_primary_10_3390_foods13223654 crossref_primary_10_3390_nu14142844 crossref_primary_10_3390_nu12020307 crossref_primary_10_1136_bmjopen_2022_067990 crossref_primary_10_3390_nu16040568 crossref_primary_10_1016_j_mad_2021_111476 crossref_primary_10_1016_j_nutres_2021_04_002 crossref_primary_10_1146_annurev_food_030117_012545 crossref_primary_10_3390_nu12092555 crossref_primary_10_3390_nu15061365 crossref_primary_10_1016_S0140_6736_19_31138_9 crossref_primary_10_1097_MCO_0000000000000648 crossref_primary_10_1016_j_plefa_2022_102531 crossref_primary_10_3390_ijms241310717 crossref_primary_10_1016_j_metabol_2024_156052 crossref_primary_10_1186_s12944_019_0983_x crossref_primary_10_3389_fnut_2019_00102 crossref_primary_10_1016_j_metabol_2023_155585 crossref_primary_10_1016_j_plefa_2019_08_006 crossref_primary_10_1111_jfbc_12435 crossref_primary_10_1186_s40814_024_01561_w crossref_primary_10_3390_md22030113 crossref_primary_10_1016_j_jff_2019_03_022 crossref_primary_10_1152_japplphysiol_00878_2019 crossref_primary_10_3390_nu15132926 crossref_primary_10_29105_respyn23_1_775 crossref_primary_10_1093_ajcn_nqac166 crossref_primary_10_1371_journal_pone_0139174 crossref_primary_10_1007_s12032_021_01625_4 crossref_primary_10_1007_s42978_019_00037_1 crossref_primary_10_1016_j_freeradbiomed_2022_11_017 crossref_primary_10_14814_phy2_13530 crossref_primary_10_3945_ajcn_116_140780 crossref_primary_10_3390_nu12072057 crossref_primary_10_1007_s11357_023_00789_3 crossref_primary_10_3389_fcell_2022_964130 crossref_primary_10_1017_S095442242300001X crossref_primary_10_21320_1818_474X_2021_2_94_102 crossref_primary_10_1007_s10522_016_9637_9 crossref_primary_10_1051_ocl_2024011 crossref_primary_10_1093_gerona_glaa042 crossref_primary_10_1111_nbu_12351 crossref_primary_10_3390_nu11122942 crossref_primary_10_3389_fnut_2022_869351 crossref_primary_10_1038_s41598_022_16120_7 crossref_primary_10_1002_jcsm_12936 crossref_primary_10_1016_j_clnesp_2021_09_729 crossref_primary_10_1093_jn_nxab109 crossref_primary_10_1016_j_exger_2018_07_006 crossref_primary_10_1016_j_clnu_2020_03_018 crossref_primary_10_3390_nu12020325 crossref_primary_10_1016_j_advnut_2023_04_012 crossref_primary_10_1136_bjsports_2018_099889 crossref_primary_10_1016_j_arr_2023_102014 crossref_primary_10_3390_nu15163613 crossref_primary_10_1093_jn_nxy063 crossref_primary_10_1016_j_semarthrit_2020_05_008 crossref_primary_10_1016_j_jff_2021_104755 crossref_primary_10_1016_j_afos_2022_04_001 crossref_primary_10_1016_j_exger_2023_112177 crossref_primary_10_1016_j_exger_2020_110964 crossref_primary_10_1016_j_plefa_2021_102249 crossref_primary_10_3390_md19050262 crossref_primary_10_1080_15438627_2018_1550401 crossref_primary_10_1093_ajcn_nqaa447 crossref_primary_10_1016_j_afos_2022_12_002 crossref_primary_10_1016_j_ijbiomac_2024_131547 crossref_primary_10_1093_ajcn_nqaa449 crossref_primary_10_1016_j_clnesp_2020_11_015 crossref_primary_10_3390_nu10081099 crossref_primary_10_3389_fnut_2024_1377910 crossref_primary_10_1007_s11357_020_00272_3 crossref_primary_10_1007_s11864_023_01122_y crossref_primary_10_1017_S0007114517003385 crossref_primary_10_1016_j_cmet_2022_08_012 crossref_primary_10_1080_10408398_2021_1939262 crossref_primary_10_1002_prp2_70019 crossref_primary_10_1016_j_autrev_2024_103738 crossref_primary_10_1152_ajpendo_00184_2020 crossref_primary_10_1007_s41999_017_0003_5 crossref_primary_10_1002_ncp_10540 crossref_primary_10_1016_j_maturitas_2020_06_012 crossref_primary_10_1016_j_exger_2020_111105 crossref_primary_10_3390_md13116977 crossref_primary_10_1007_s40519_020_00863_1 crossref_primary_10_7762_cnr_2023_12_4_304 crossref_primary_10_3390_metabo12111149 crossref_primary_10_3390_nu13062045 crossref_primary_10_1007_s40200_023_01262_w crossref_primary_10_1097_MCO_0000000000000441 crossref_primary_10_3390_diseases13010003 crossref_primary_10_1123_japa_2017_0404 crossref_primary_10_1016_j_jjcc_2021_10_013 crossref_primary_10_14283_jfa_2021_4 crossref_primary_10_3389_fnut_2023_1247594 crossref_primary_10_1007_s00394_016_1195_z crossref_primary_10_1371_journal_pone_0144828 crossref_primary_10_1016_j_clnu_2024_04_033 crossref_primary_10_3390_nu15204386 crossref_primary_10_1007_s11357_021_00419_w crossref_primary_10_1038_s41598_021_84479_0 crossref_primary_10_1093_ajcn_nqab310 crossref_primary_10_1016_j_rvsc_2020_01_008 crossref_primary_10_3390_nu14194060 crossref_primary_10_1007_s12272_021_01349_z crossref_primary_10_3390_metabo14060340 crossref_primary_10_1016_j_ajcnut_2023_08_015 crossref_primary_10_3389_fnut_2024_1423576 crossref_primary_10_2174_1871520622666220330142442 crossref_primary_10_1093_mr_roac095 crossref_primary_10_1016_j_clnu_2023_09_027 crossref_primary_10_1016_j_exger_2021_111651 crossref_primary_10_3389_fnut_2021_645072 crossref_primary_10_53520_jen2022_103116 crossref_primary_10_3390_antiox10091415 crossref_primary_10_3390_nu14173537 crossref_primary_10_3390_healthcare10101980 crossref_primary_10_3390_nu14214566 crossref_primary_10_1080_27697061_2025_2472656 crossref_primary_10_1371_journal_pone_0181387 crossref_primary_10_1016_j_advnut_2023_03_014 crossref_primary_10_1155_2018_7625981 crossref_primary_10_1111_jfbc_12980 crossref_primary_10_3390_nu13051409 crossref_primary_10_2214_AJR_16_17226 crossref_primary_10_3390_jal5010004 crossref_primary_10_1007_s13668_025_00637_0 crossref_primary_10_1016_j_clnu_2017_08_016 crossref_primary_10_3390_nu14030483 crossref_primary_10_3390_nu10030309 crossref_primary_10_1017_S002966511500422X crossref_primary_10_1152_ajpendo_00230_2016 crossref_primary_10_1007_s13670_019_00294_6 crossref_primary_10_1155_2020_8062017 crossref_primary_10_14814_phy2_12715 crossref_primary_10_1007_s11332_016_0322_9 crossref_primary_10_1007_s40473_017_0126_5 crossref_primary_10_1002_agm2_12245 crossref_primary_10_1093_nutrit_nuaa064 crossref_primary_10_1080_19390211_2021_1897057 crossref_primary_10_3389_fnut_2023_1189522 crossref_primary_10_1113_JP275443 crossref_primary_10_1017_S0029665119000922 crossref_primary_10_1007_s12603_020_1318_3 crossref_primary_10_1016_j_nut_2022_111829 crossref_primary_10_3390_nu12102959 crossref_primary_10_1080_10408398_2022_2034734 crossref_primary_10_1016_j_monrhu_2019_01_003 crossref_primary_10_1097_MCO_0000000000000330 crossref_primary_10_1080_15502783_2024_2441775 crossref_primary_10_1097_MCO_0000000000000333 crossref_primary_10_3390_nu12020481 crossref_primary_10_1093_gerona_gly226 crossref_primary_10_3390_md22100446 crossref_primary_10_1080_10408398_2021_1969889 crossref_primary_10_1080_87559129_2024_2392154 crossref_primary_10_17987_jcsm_cr_v3i2_72 crossref_primary_10_3390_nu15214516 crossref_primary_10_1093_ageing_afac274 crossref_primary_10_1172_JCI158451 crossref_primary_10_1016_j_phrs_2024_107384 crossref_primary_10_1093_ajcn_nqaa136 crossref_primary_10_1016_j_metabol_2023_155637 crossref_primary_10_1016_j_jamda_2015_10_001 crossref_primary_10_3390_nu15071574 crossref_primary_10_3390_foods11050687 crossref_primary_10_1007_s12603_020_1553_7 crossref_primary_10_1016_j_jff_2017_03_048 crossref_primary_10_1016_j_cnd_2018_06_002 crossref_primary_10_3164_jcbn_19_85 crossref_primary_10_3390_cells12192422 crossref_primary_10_1007_s40279_021_01509_7 crossref_primary_10_1016_j_phrs_2019_02_030 crossref_primary_10_12677_ACM_2023_1361379 crossref_primary_10_3390_nu17050858 crossref_primary_10_1002_lite_201500063 crossref_primary_10_18632_oncotarget_10171 crossref_primary_10_23736_S2724_5683_24_06496_2 crossref_primary_10_3390_nu13113824 crossref_primary_10_1186_s12983_019_0312_2 crossref_primary_10_3390_nu12030622 crossref_primary_10_1016_j_clnu_2022_07_041 crossref_primary_10_1155_2016_4301621 crossref_primary_10_1093_gerona_gly130 crossref_primary_10_3390_nu12123739 crossref_primary_10_3389_fnut_2023_1164469 crossref_primary_10_1007_s10522_021_09932_z crossref_primary_10_1016_j_exger_2018_08_001 crossref_primary_10_1007_s10098_022_02348_4 crossref_primary_10_1249_MSS_0000000000002195 crossref_primary_10_1038_s41467_020_19501_6 crossref_primary_10_1016_j_clnu_2019_01_009 crossref_primary_10_1016_j_jare_2023_04_005 crossref_primary_10_1007_s11154_023_09821_5 crossref_primary_10_3390_antiox12051050 crossref_primary_10_1590_1980_5918_033_ao11 crossref_primary_10_1016_j_scp_2017_03_001 crossref_primary_10_1016_j_metabol_2016_10_007 crossref_primary_10_3390_life14111426 crossref_primary_10_1016_j_clnu_2019_01_001 crossref_primary_10_1016_j_nutres_2018_02_006 crossref_primary_10_3390_nu12051533 crossref_primary_10_3390_md17060380 crossref_primary_10_1515_opag_2020_0003 |
| Cites_doi | 10.1093/gerona/60.3.324 10.1186/1476-511X-11-142 10.1093/gerona/glr055 10.1016/j.jamda.2010.04.014 10.1210/jc.2005-0957 10.1073/pnas.0610131104 10.1016/j.plefa.2010.08.003 10.1152/japplphysiol.00299.2006 10.1093/gerona/55.6.M350 10.1056/NEJMoa1008234 10.1093/ageing/23.5.371 10.1111/j.1532-5415.2011.03410.x 10.1152/ajpendo.00414.2001 10.3945/ajcn.111.021915 10.3945/ajcn.110.005611 10.1016/j.clnu.2014.04.007 10.1002/cncr.25709 10.2337/diabetes.48.1.134 10.1093/gerona/61.10.1059 10.1111/j.1532-5415.2004.52310.x 10.1016/S0022-2275(20)30164-4 10.1093/gerona/gls196 10.1016/j.jamda.2011.01.003 10.1093/gerona/61.1.72 10.1016/S0021-9258(18)64849-5 10.1097/00005768-200207000-00023 10.1016/j.nut.2004.03.023 10.1111/j.1532-5415.1987.tb01313.x 10.1001/jama.2007.51 10.1007/s00421-011-2099-5 10.1111/j.1532-5415.2000.tb02632.x 10.1161/01.CIR.0000038493.65177.94 10.1016/j.ypmed.2004.04.003 10.1093/gerona/glq012 10.1093/ajcn/87.5.1554S 10.2522/ptj.20060176 10.1093/ageing/afs089 10.1152/japplphysiol.00853.2006 10.1210/jcem-73-5-1111 10.1093/ageing/afq034 10.1093/gerona/gls254 10.1080/09638280410001704304 |
| ContentType | Journal Article |
| Copyright | 2015 American Society for Nutrition. Copyright American Society for Clinical Nutrition, Inc. Jul 1, 2015 2015 American Society for Nutrition 2015 |
| Copyright_xml | – notice: 2015 American Society for Nutrition. – notice: Copyright American Society for Clinical Nutrition, Inc. Jul 1, 2015 – notice: 2015 American Society for Nutrition 2015 |
| DBID | FBQ AAYXX CITATION CGR CUY CVF ECM EIF NPM 7QP 7T7 7TS 8FD C1K FR3 K9. NAPCQ P64 7X8 7S9 L.6 5PM |
| DOI | 10.3945/ajcn.114.105833 |
| DatabaseName | AGRIS CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Calcium & Calcified Tissue Abstracts Industrial and Applied Microbiology Abstracts (Microbiology A) Physical Education Index Technology Research Database Environmental Sciences and Pollution Management Engineering Research Database ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium Biotechnology and BioEngineering Abstracts MEDLINE - Academic AGRICOLA AGRICOLA - Academic PubMed Central (Full Participant titles) |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Nursing & Allied Health Premium Technology Research Database ProQuest Health & Medical Complete (Alumni) Engineering Research Database Industrial and Applied Microbiology Abstracts (Microbiology A) Calcium & Calcified Tissue Abstracts Physical Education Index Biotechnology and BioEngineering Abstracts Environmental Sciences and Pollution Management MEDLINE - Academic AGRICOLA AGRICOLA - Academic |
| DatabaseTitleList | Nursing & Allied Health Premium AGRICOLA MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: FBQ name: AGRIS url: http://www.fao.org/agris/Centre.asp?Menu_1ID=DB&Menu_2ID=DB1&Language=EN&Content=http://www.fao.org/agris/search?Language=EN sourceTypes: Publisher |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Diet & Clinical Nutrition |
| EISSN | 1938-3207 |
| EndPage | 122 |
| ExternalDocumentID | PMC4480667 3738686801 25994567 10_3945_ajcn_114_105833 US201600086683 |
| Genre | Randomized Controlled Trial Journal Article Research Support, N.I.H., Extramural |
| GrantInformation_xml | – fundername: NIDDK NIH HHS grantid: P60 DK020579 – fundername: NCATS NIH HHS grantid: TR 000450 – fundername: NIDDK NIH HHS grantid: DK 56341 – fundername: NIDDK NIH HHS grantid: P30 DK020579 – fundername: NCATS NIH HHS grantid: KL2 TR000450 – fundername: NIDDK NIH HHS grantid: DK 20579 – fundername: NIDDK NIH HHS grantid: P30 DK056341 – fundername: NCATS NIH HHS grantid: UL1 TR000448 |
| GroupedDBID | --- -ET -~X ..I .55 .GJ 0R~ 1HT 23M 2FS 2WC 3O- 4.4 476 48X 53G 5GY 5RE 5VS 6J9 85S 8R4 8R5 A8Z AABJS AABMN AABZA AACZT AAIKC AAJQQ AAMNW AAPGJ AAPQZ AAUQX AAUTI AAVAP AAWDT AAWTL AAXUO AAYOK ABBTP ABDNZ ABJNI ABLJU ABOCM ABPTD ABSAR ABSGY ABWST ACFRR ACGFO ACGFS ACGOD ACIMA ACNCT ACPRK ACPVT ACUFI ACUTJ ADBBV ADEIU ADGZP ADHUB ADRTK ADVEK AEGXH AENEX AEQTP AETBJ AFDAS AFFDN AFFNX AFFZL AFMIJ AFOFC AFRAH AFXAL AGINJ AGNAY AGQXC AGUTN AHMBA AI. AIAGR AIKOY AIMBJ AJEEA ALMA_UNASSIGNED_HOLDINGS ALXQX AMRAJ ANFBD AQDSO AQKUS ASMCH AZQFJ BAWUL BAYMD BCRHZ BEYMZ BKOMP BTRTY BYORX C1A CASEJ CDBKE DAKXR DIK DPPUQ E3Z EBS EIHJH EJD ENERS EX3 F5P F9R FBQ FDB FECEO FOTVD FQBLK FRP G8K GAUVT GJXCC GX1 HF~ HZ~ I4R IH2 J5H KBUDW KOP KQ8 KSI KSN L7B LPU MBLQV MHKGH MV1 MVM N4W NEJ NHB NHCRO NOMLY NOYVH NVLIB O9- OAUYM OBFPC ODMLO OHT OJZSN OK1 OPAEJ OVD P2P P6G PCD PQQKQ PRG Q2X R0Z RHF RHI RNS ROL ROX SJN SV3 TCN TEORI TMA TNT TR2 TWZ UBH UHB UKR VH1 W2D W8F WH7 WHG WOQ WOW X7M XOL XSW YBU YHG YOJ YQJ YRY YSK YV5 YYQ YZZ ZA5 ZCA ZCG ZGI ZUP ZXP ~KM AAGQS AAHBH AALRI AAYWO AAYXX ABDPE ABIME ACVFH ADCNI ADMTO ADUKH ADVLN AEUPX AFJKZ AFPUW AGCQF AGKRT AIGII AITUG AKBMS AKRWK AKYEP APXCP CITATION FLUFQ FOEOM H13 NU- YR5 CGR CUY CVF ECM EIF NPM VXZ Z5M 7QP 7T7 7TS 8FD C1K EFKBS FR3 K9. NAPCQ P64 7X8 7S9 L.6 5PM |
| ID | FETCH-LOGICAL-c577t-99a04fa293246f08ef2a4fe865a84784d2d4ffca425f9496802fd7e707b33753 |
| ISSN | 0002-9165 |
| IngestDate | Thu Aug 21 18:28:56 EDT 2025 Fri Jul 11 07:00:48 EDT 2025 Mon Jul 21 09:31:57 EDT 2025 Mon Jul 21 11:24:14 EDT 2025 Fri Jul 25 02:09:50 EDT 2025 Wed Feb 19 02:24:42 EST 2025 Tue Jul 01 04:03:04 EDT 2025 Thu Apr 24 22:51:27 EDT 2025 Wed Dec 27 19:24:57 EST 2023 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | muscle mass muscle strength omega-3 fatty acids aging muscle power |
| Language | English |
| License | 2015 American Society for Nutrition. |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c577t-99a04fa293246f08ef2a4fe865a84784d2d4ffca425f9496802fd7e707b33753 |
| Notes | http://dx.doi.org/10.3945/ajcn.114.105833 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 ObjectType-Undefined-3 Supported by NIH grants DK 56341 (Nutrition and Obesity Research Center), DK 20579 (Diabetes Research Center), and UL1 TR000448 (Clinical Translational Science Award, including KL2 subaward TR 000450) and a gift (study drugs) from GlaxoSmithKline plc. |
| OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/4480667 |
| PMID | 25994567 |
| PQID | 1695033044 |
| PQPubID | 41076 |
| PageCount | 8 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_4480667 proquest_miscellaneous_1825813719 proquest_miscellaneous_1803119548 proquest_miscellaneous_1693706940 proquest_journals_1695033044 pubmed_primary_25994567 crossref_citationtrail_10_3945_ajcn_114_105833 crossref_primary_10_3945_ajcn_114_105833 fao_agris_US201600086683 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2015-07-01 |
| PublicationDateYYYYMMDD | 2015-07-01 |
| PublicationDate_xml | – month: 07 year: 2015 text: 2015-07-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States – name: Bethesda |
| PublicationTitle | The American journal of clinical nutrition |
| PublicationTitleAlternate | Am J Clin Nutr |
| PublicationYear | 2015 |
| Publisher | American Society for Clinical Nutrition American Society for Clinical Nutrition, Inc American Society for Nutrition |
| Publisher_xml | – name: American Society for Clinical Nutrition – name: American Society for Clinical Nutrition, Inc – name: American Society for Nutrition |
| References | Whitehouse (10.3945/ajcn.114.105833_bib40) 2001; 61 Vaughan (10.3945/ajcn.114.105833_bib44) 2012; 11 Skelton (10.3945/ajcn.114.105833_bib4) 1994; 23 Pearson (10.3945/ajcn.114.105833_bib21) 2002; 34 Coen (10.3945/ajcn.114.105833_bib42) 2013; 68 Deutz (10.3945/ajcn.114.105833_bib15) 2014; 33 Baker (10.3945/ajcn.114.105833_bib23) 2011; 59 Smith (10.3945/ajcn.114.105833_bib39) 2011; 93 Korhonen (10.3945/ajcn.114.105833_bib22) 2006; 101 Cruz-Jentoft (10.3945/ajcn.114.105833_bib2) 2010; 39 Folch (10.3945/ajcn.114.105833_bib33) 1957; 226 Brown (10.3945/ajcn.114.105833_bib29) 2000; 55 Schutzer (10.3945/ajcn.114.105833_bib18) 2004; 39 Berbert (10.3945/ajcn.114.105833_bib27) 2005; 21 Fulgoni (10.3945/ajcn.114.105833_bib17) 2008; 87 Whipple (10.3945/ajcn.114.105833_bib10) 1987; 35 Neschen (10.3945/ajcn.114.105833_bib45) 2002; 282 Weiss (10.3945/ajcn.114.105833_bib35) 2007; 102 Kris-Etherton (10.3945/ajcn.114.105833_bib32) 2002; 106 Schoenborn (10.3945/ajcn.114.105833_bib19) 2013; 257 Newman (10.3945/ajcn.114.105833_bib14) 2006; 61 Murphy (10.3945/ajcn.114.105833_bib26) 2011; 117 Fielding (10.3945/ajcn.114.105833_bib1) 2011; 12 Morley (10.3945/ajcn.114.105833_bib16) 2010; 11 Ishizaki (10.3945/ajcn.114.105833_bib5) 2000; 48 Emmelot-Vonk (10.3945/ajcn.114.105833_bib24) 2008; 299 Visser (10.3945/ajcn.114.105833_bib31) 2005; 60 Goodpaster (10.3945/ajcn.114.105833_bib3) 2006; 61 Giannoulis (10.3945/ajcn.114.105833_bib25) 2006; 91 Roberts (10.3945/ajcn.114.105833_bib13) 2012; 41 Hicks (10.3945/ajcn.114.105833_bib6) 2012; 67 Rodacki (10.3945/ajcn.114.105833_bib28) 2012; 95 Patterson (10.3945/ajcn.114.105833_bib34) 2002; 43 Barbat-Artigas (10.3945/ajcn.114.105833_bib8) 2013; 68 Moreland (10.3945/ajcn.114.105833_bib12) 2004; 52 Puthoff (10.3945/ajcn.114.105833_bib37) 2007; 87 Amara (10.3945/ajcn.114.105833_bib41) 2007; 104 Wolfson (10.3945/ajcn.114.105833_bib9) 1995; 50 Lim (10.3945/ajcn.114.105833_bib46) 2010; 83 Grady (10.3945/ajcn.114.105833_bib36) 1991; 73 Sieri (10.3945/ajcn.114.105833_bib11) 2004; 26 Jucker (10.3945/ajcn.114.105833_bib43) 1999; 48 Fukumoto (10.3945/ajcn.114.105833_bib30) 2012; 112 Villareal (10.3945/ajcn.114.105833_bib38) 2011; 364 Clark (10.3945/ajcn.114.105833_bib7) 2010; 65 Adams (10.3945/ajcn.114.105833_bib20) 1990; 176 |
| References_xml | – volume: 60 start-page: 324 year: 2005 ident: 10.3945/ajcn.114.105833_bib31 article-title: Muscle mass, muscle strength, and muscle fat infiltration as predictors of incident mobility limitations in well-functioning older persons publication-title: J Gerontol A Biol Sci Med Sci doi: 10.1093/gerona/60.3.324 – volume: 11 start-page: 142 year: 2012 ident: 10.3945/ajcn.114.105833_bib44 article-title: Conjugated linoleic acid or omega 3 fatty acids increase mitochondrial biosynthesis and metabolism in skeletal muscle cells publication-title: Lipids Health Dis doi: 10.1186/1476-511X-11-142 – volume: 67 start-page: 66 year: 2012 ident: 10.3945/ajcn.114.105833_bib6 article-title: Absolute strength and loss of strength as predictors of mobility decline in older adults: the InCHIANTI study publication-title: J Gerontol A Biol Sci Med Sci doi: 10.1093/gerona/glr055 – volume: 11 start-page: 391 year: 2010 ident: 10.3945/ajcn.114.105833_bib16 article-title: Nutritional recommendations for the management of sarcopenia publication-title: J Am Med Dir Assoc doi: 10.1016/j.jamda.2010.04.014 – volume: 91 start-page: 477 year: 2006 ident: 10.3945/ajcn.114.105833_bib25 article-title: The effects of growth hormone and/or testosterone in healthy elderly men: a randomized controlled trial publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2005-0957 – volume: 104 start-page: 1057 year: 2007 ident: 10.3945/ajcn.114.105833_bib41 article-title: Mild mitochondrial uncoupling impacts cellular aging in human muscles in vivo publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.0610131104 – volume: 83 start-page: 193 year: 2010 ident: 10.3945/ajcn.114.105833_bib46 article-title: The acute administration of eicosapentaenoic acid is neuroprotective after spinal cord compression injury in rats publication-title: Prostaglandins Leukot Essent Fatty Acids doi: 10.1016/j.plefa.2010.08.003 – volume: 101 start-page: 906 year: 2006 ident: 10.3945/ajcn.114.105833_bib22 article-title: Aging, muscle fiber type, and contractile function in sprint-trained athletes publication-title: J Appl Physiol (1985) doi: 10.1152/japplphysiol.00299.2006 – volume: 55 start-page: M350 year: 2000 ident: 10.3945/ajcn.114.105833_bib29 article-title: Physical and performance measures for the identification of mild to moderate frailty publication-title: J Gerontol A Biol Sci Med Sci doi: 10.1093/gerona/55.6.M350 – volume: 364 start-page: 1218 year: 2011 ident: 10.3945/ajcn.114.105833_bib38 article-title: Weight loss, exercise, or both and physical function in obese older adults publication-title: N Engl J Med doi: 10.1056/NEJMoa1008234 – volume: 23 start-page: 371 year: 1994 ident: 10.3945/ajcn.114.105833_bib4 article-title: Strength, power and related functional ability of healthy people aged 65-89 years publication-title: Age Ageing doi: 10.1093/ageing/23.5.371 – volume: 59 start-page: 997 year: 2011 ident: 10.3945/ajcn.114.105833_bib23 article-title: Effect of dehydroepiandrosterone on muscle strength and physical function in older adults: a systematic review publication-title: J Am Geriatr Soc doi: 10.1111/j.1532-5415.2011.03410.x – volume: 282 start-page: E395 year: 2002 ident: 10.3945/ajcn.114.105833_bib45 article-title: Contrasting effects of fish oil and safflower oil on hepatic peroxisomal and tissue lipid content publication-title: Am J Physiol Endocrinol Metab doi: 10.1152/ajpendo.00414.2001 – volume: 95 start-page: 428 year: 2012 ident: 10.3945/ajcn.114.105833_bib28 article-title: Fish-oil supplementation enhances the effects of strength training in elderly women publication-title: Am J Clin Nutr doi: 10.3945/ajcn.111.021915 – volume: 93 start-page: 402 year: 2011 ident: 10.3945/ajcn.114.105833_bib39 article-title: Dietary omega-3 fatty acid supplementation increases the rate of muscle protein synthesis in older adults: a randomized controlled trial publication-title: Am J Clin Nutr doi: 10.3945/ajcn.110.005611 – volume: 33 start-page: 929 year: 2014 ident: 10.3945/ajcn.114.105833_bib15 article-title: Protein intake and exercise for optimal muscle function with aging: Recommendations from the ESPEN Expert Group publication-title: Clin Nutr doi: 10.1016/j.clnu.2014.04.007 – volume: 117 start-page: 1775 year: 2011 ident: 10.3945/ajcn.114.105833_bib26 article-title: Nutritional intervention with fish oil provides a benefit over standard of care for weight and skeletal muscle mass in patients with nonsmall cell lung cancer receiving chemotherapy publication-title: Cancer doi: 10.1002/cncr.25709 – volume: 48 start-page: 134 year: 1999 ident: 10.3945/ajcn.114.105833_bib43 article-title: Differential effects of safflower oil versus fish oil feeding on insulin-stimulated glycogen synthesis, glycolysis, and pyruvate dehydrogenase flux in skeletal muscle: a 13C nuclear magnetic resonance study publication-title: Diabetes doi: 10.2337/diabetes.48.1.134 – volume: 257 start-page: 1 year: 2013 ident: 10.3945/ajcn.114.105833_bib19 article-title: Health behaviors of adults: United States, 2008-2010 publication-title: Vital Health Stat 10 – volume: 61 start-page: 1059 year: 2006 ident: 10.3945/ajcn.114.105833_bib3 article-title: The loss of skeletal muscle strength, mass, and quality in older adults: the health, aging and body composition study publication-title: J Gerontol A Biol Sci Med Sci doi: 10.1093/gerona/61.10.1059 – volume: 52 start-page: 1121 year: 2004 ident: 10.3945/ajcn.114.105833_bib12 article-title: Muscle weakness and falls in older adults: a systematic review and meta-analysis publication-title: J Am Geriatr Soc doi: 10.1111/j.1532-5415.2004.52310.x – volume: 176 start-page: 1 year: 1990 ident: 10.3945/ajcn.114.105833_bib20 article-title: Current estimates from the National Health interview survey, 1989 publication-title: Vital Health Stat 10 – volume: 43 start-page: 223 year: 2002 ident: 10.3945/ajcn.114.105833_bib34 article-title: Use of stable isotopically labeled tracers to measure very low density lipoprotein-triglyceride turnover publication-title: J Lipid Res doi: 10.1016/S0022-2275(20)30164-4 – volume: 68 start-page: 447 year: 2013 ident: 10.3945/ajcn.114.105833_bib42 article-title: Skeletal muscle mitochondrial energetics are associated with maximal aerobic capacity and walking speed in older adults publication-title: J Gerontol A Biol Sci Med Sci doi: 10.1093/gerona/gls196 – volume: 12 start-page: 249 year: 2011 ident: 10.3945/ajcn.114.105833_bib1 article-title: Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia publication-title: J Am Med Dir Assoc doi: 10.1016/j.jamda.2011.01.003 – volume: 61 start-page: 72 year: 2006 ident: 10.3945/ajcn.114.105833_bib14 article-title: Strength, but not muscle mass, is associated with mortality in the health, aging and body composition study cohort publication-title: J Gerontol A Biol Sci Med Sci doi: 10.1093/gerona/61.1.72 – volume: 226 start-page: 497 year: 1957 ident: 10.3945/ajcn.114.105833_bib33 article-title: A simple method for the isolation and purification of total lipides from animal tissues publication-title: J Biol Chem doi: 10.1016/S0021-9258(18)64849-5 – volume: 34 start-page: 1199 year: 2002 ident: 10.3945/ajcn.114.105833_bib21 article-title: Muscle function in elite master weightlifters publication-title: Med Sci Sports Exerc doi: 10.1097/00005768-200207000-00023 – volume: 21 start-page: 131 year: 2005 ident: 10.3945/ajcn.114.105833_bib27 article-title: Supplementation of fish oil and olive oil in patients with rheumatoid arthritis publication-title: Nutrition doi: 10.1016/j.nut.2004.03.023 – volume: 35 start-page: 13 year: 1987 ident: 10.3945/ajcn.114.105833_bib10 article-title: The relationship of knee and ankle weakness to falls in nursing home residents: an isokinetic study publication-title: J Am Geriatr Soc doi: 10.1111/j.1532-5415.1987.tb01313.x – volume: 299 start-page: 39 year: 2008 ident: 10.3945/ajcn.114.105833_bib24 article-title: Effect of testosterone supplementation on functional mobility, cognition, and other parameters in older men: a randomized controlled trial publication-title: JAMA doi: 10.1001/jama.2007.51 – volume: 112 start-page: 1519 year: 2012 ident: 10.3945/ajcn.114.105833_bib30 article-title: Skeletal muscle quality assessed from echo intensity is associated with muscle strength of middle-aged and elderly persons publication-title: Eur J Appl Physiol doi: 10.1007/s00421-011-2099-5 – volume: 48 start-page: 1424 year: 2000 ident: 10.3945/ajcn.114.105833_bib5 article-title: Predictors for functional decline among nondisabled older Japanese living in a community during a 3-year follow-up publication-title: J Am Geriatr Soc doi: 10.1111/j.1532-5415.2000.tb02632.x – volume: 106 start-page: 2747 year: 2002 ident: 10.3945/ajcn.114.105833_bib32 article-title: Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease publication-title: Circulation doi: 10.1161/01.CIR.0000038493.65177.94 – volume: 61 start-page: 3604 year: 2001 ident: 10.3945/ajcn.114.105833_bib40 article-title: Mechanism of attenuation of skeletal muscle protein catabolism in cancer cachexia by eicosapentaenoic acid publication-title: Cancer Res – volume: 39 start-page: 1056 year: 2004 ident: 10.3945/ajcn.114.105833_bib18 article-title: Barriers and motivations to exercise in older adults publication-title: Prev Med doi: 10.1016/j.ypmed.2004.04.003 – volume: 65 start-page: 495 year: 2010 ident: 10.3945/ajcn.114.105833_bib7 article-title: Impaired voluntary neuromuscular activation limits muscle power in mobility-limited older adults publication-title: J Gerontol A Biol Sci Med Sci doi: 10.1093/gerona/glq012 – volume: 87 start-page: 1554S year: 2008 ident: 10.3945/ajcn.114.105833_bib17 article-title: Current protein intake in America: analysis of the National Health and Nutrition Examination Survey, 2003-2004 publication-title: Am J Clin Nutr doi: 10.1093/ajcn/87.5.1554S – volume: 87 start-page: 1334 year: 2007 ident: 10.3945/ajcn.114.105833_bib37 article-title: Relationships among impairments in lower-extremity strength and power, functional limitations, and disability in older adults publication-title: Phys Ther doi: 10.2522/ptj.20060176 – volume: 41 start-page: 641 year: 2012 ident: 10.3945/ajcn.114.105833_bib13 article-title: Is grip strength associated with length of stay in hospitalised older patients admitted for rehabilitation? Findings from the Southampton grip strength study publication-title: Age Ageing doi: 10.1093/ageing/afs089 – volume: 102 start-page: 634 year: 2007 ident: 10.3945/ajcn.114.105833_bib35 article-title: Lower extremity muscle size and strength and aerobic capacity decrease with caloric restriction but not with exercise-induced weight loss publication-title: J Appl Physiol doi: 10.1152/japplphysiol.00853.2006 – volume: 73 start-page: 1111 year: 1991 ident: 10.3945/ajcn.114.105833_bib36 article-title: 1,25-Dihydroxyvitamin D3 and muscle strength in the elderly: a randomized controlled trial publication-title: J Clin Endocrinol Metab doi: 10.1210/jcem-73-5-1111 – volume: 39 start-page: 412 year: 2010 ident: 10.3945/ajcn.114.105833_bib2 article-title: Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People publication-title: Age Ageing doi: 10.1093/ageing/afq034 – volume: 68 start-page: 811 year: 2013 ident: 10.3945/ajcn.114.105833_bib8 article-title: Clinical relevance of different muscle strength indexes and functional impairment in women aged 75 years and older publication-title: J Gerontol A Biol Sci Med Sci doi: 10.1093/gerona/gls254 – volume: 50 start-page: 64 year: 1995 ident: 10.3945/ajcn.114.105833_bib9 article-title: Strength is a major factor in balance, gait, and the occurrence of falls publication-title: J Gerontol A Biol Sci Med Sci – volume: 26 start-page: 718 year: 2004 ident: 10.3945/ajcn.114.105833_bib11 article-title: Fall risk assessment in very old males and females living in nursing homes publication-title: Disabil Rehabil doi: 10.1080/09638280410001704304 |
| SSID | ssj0012486 |
| Score | 2.6148863 |
| Snippet | Background: Age-associated declines in muscle mass and function are major risk factors for an impaired ability to carry out activities of daily living, falls,... Age-associated declines in muscle mass and function are major risk factors for an impaired ability to carry out activities of daily living, falls, prolonged... BACKGROUNDAge-associated declines in muscle mass and function are major risk factors for an impaired ability to carry out activities of daily living, falls,... Background: Age-associated declines in muscle mass and function are major risk factors for an impaired ability to carry out activities of daily living, falls,... |
| SourceID | pubmedcentral proquest pubmed crossref fao |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 115 |
| SubjectTerms | Activities of Daily Living Adipose Tissue - drug effects Aged Aged, 80 and over Aging Body Composition Body Weight - drug effects corn oil Double-Blind Method elderly Erythrocytes - drug effects Erythrocytes - metabolism Fatty acids Fatty Acids, Omega-3 - administration & dosage Female fish Fish oils Fish Oils - administration & dosage Hand Strength Hospitalization Humans Male men Middle Aged Mortality muscle strength Muscle Strength - drug effects Muscle, Skeletal - drug effects Muscle, Skeletal - metabolism muscles Older people omega-3 fatty acids polyunsaturated fatty acids Risk factors risk reduction sarcopenia Sarcopenia - prevention & control therapeutics Treatment Outcome women |
| Title | Fish oil–derived n–3 PUFA therapy increases muscle mass and function in healthy older adults |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/25994567 https://www.proquest.com/docview/1695033044 https://www.proquest.com/docview/1693706940 https://www.proquest.com/docview/1803119548 https://www.proquest.com/docview/1825813719 https://pubmed.ncbi.nlm.nih.gov/PMC4480667 |
| Volume | 102 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLZ2kRAvCMZlhYGMhBBS1ZHYTuw8ToMxbeo0ba3YW3CTeCvq0om2SPDEf-DH8c4v4ZzY8dJuTLCXKEqcusn5fC72OZ8JeZVInrGAFx2wzXlHZGHc0RIHnooVEyrOQo3zkN2DeLcv9k6ik6WlX42spdl0sJl9v7au5DZShWsgV6yS_Q_J-h-FC3AO8oUjSBiO_yRj3Le8PR6O6owFnkOvX3FB31_h7cP-TpW6geQB7WGJXuKkmLTPZxP4tfY5OM_VAgIauDrx0RZHfmuPcQtvS9ExaXqxvctylLLJPeHLLMua4__KBM4HCHahEz9Xu4eLUS658nh8cTb0QDsCu-p8fOQ_yRqLRsNSZy4_uMrJd1mPbvIijHyi67RRL4CKrJGiejD3Fy_1Njiydv27sKo6AVXNmd0z1-vygF0BrdXMYRg1jHxoi6EX7QdPBFJt6M9ZiSTKuAmysjwdDTRdnFdwgrgRWtu9RBYouw-72xD1YvrwMlllEL-wFbK6tX_0cd8vcOE4qCMzfDHLOoX9v13oHemqXVdzvtOy0ePrwqLF7N6Gu9S7T-65OIduWdA-IEtFuUZa7-Dz09fUkdGOqBfCGrnTdVkeD8knxDUFXP_-8dMhmpZwzilimTosU49larFMEcsUsERrLEMT6rBMKyxTi-VHpLfzvre923E7gXSySMppJ0l0IIwG15SJ2ASqMEwLU6g40uBdKZGzXBiTaTBAJhFJrAJmclnIQA44h4D8MVkpx2WxTmgRR0JzyVQSGTGQPDE5-LRRkA1CJYw0LbJZf-I0cyz5uFnLKIVoGcWToniwlj-14mmRN_6BC0sQ8_em6yCzVJ-C-U77xwzJHXFKIVZwa6MWZOqG7SQN4wSTDAIhWuSlvw3qH9f0dFmMZ1UbLrF4PbihjQLLXTE73tSGRSrkMkxa5InFj3-dGn4tIueQ5RsgRf38nXJ4VlHVu2Hw9NZPPiN3L_XGBlmZfpkVzyEMmA5euCH1B-6zB-I |
| linkProvider | Library Specific Holdings |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Fish+oil%E2%80%93derived+n%E2%80%933+PUFA+therapy+increases+muscle+mass+and+function+in+healthy+older+adults&rft.jtitle=The+American+journal+of+clinical+nutrition&rft.au=Smith%2C+Gordon+I&rft.au=Julliand%2C+Sophie&rft.au=Reeds%2C+Dominic+N&rft.au=Sinacore%2C+David+R&rft.date=2015-07-01&rft.pub=American+Society+for+Nutrition&rft.issn=0002-9165&rft.eissn=1938-3207&rft.volume=102&rft.issue=1&rft.spage=115&rft.epage=122&rft_id=info:doi/10.3945%2Fajcn.114.105833&rft_id=info%3Apmid%2F25994567&rft.externalDocID=PMC4480667 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0002-9165&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0002-9165&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0002-9165&client=summon |